Short Wavelength Infrared Diimmonium Nano-Agents for Photoacoustic Imaging
En palabras de los autores
Abstract Photoacoustic imaging (PAI) as an innovative biomedical imaging modality shows high contrast and superior spatial resolution, yet remains limited by underdeveloped second near-infrared (NIR-II, 1000-1700 nm) contrast agents, particularly neglecting the NIR-IIb (1500-1700 nm) window. In this work, we designed a new class of diimmonium (DB)-based dicationic nano-agents (DB·2X, X = TFSI - , B(C 2 O 4 ) 2 - , or BF 4 - ) for 1700 nm excitation PAI. Density functional theory (DFT) calculations reveal that dicationic DB 2+ exhibits a dramatically reduced excitation energy (1.24 eV) and enhanced oscillator strength (f = 1.11) by molecular engineering, attributed to a symmetry-allowed local excitation mechanism for electronic restructuring. Single-crystal X-ray diffraction further demonstrates the intermolecular spacings >5.0 Å in DB·2X aggregates, facilitating optimized non-radiative transitions for amplified PAI signals. In vivo study using different disease models shows that DB·2TFSI nano-agents under 1700 nm excitation can achieve higher signal-to-background ratio and minimized interference from endogenous chromophores compared to conventional 1064 nm excitation. Biocompatibility assessments confirm low cytotoxicity, underscoring potential for further development of DB·2TFSI nano-agents. This work delivers a robust molecular design paradigm for non-radiative decay optimization, and for the first time establishes 1700 nm-excitable PAI nano-agents, paving the way for tissue high-quality biomedical imaging.
Apareció: miércoles, 14 de octubre. Nature Communications. Revista con revisión por pares.